Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 1 , Pages 22-25 , January 2010

G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids

Received 1 August 2008 ,Revised 13 October 2008 ,Accepted 16 February 2009.

References 

  1. Mc Garry JD, Dobbins RL. Fatty acid, lipotoxicity and insulin secretion. Diabetologia. 1999;42:128–138
  2. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, et al. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia. 1995;38:1295–1299
  3. Poitout V, Robertson RP. Secondary beta-cell failure in type 2 diabetes–a convergence of glucotoxicity and lipotoxicity. Endocrinology. 2002;143(2):339–342
  4. Bonora E. Protection of pancreatic beta-cells: is it feasible?. Nutr Metab Cardiovasc Dis. 2008;18(1):74–83
  5. Haber EP, Procopio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R. New insights into fatty acid modulation of pancreatic beta-cell function. Int Rev Cytol. 2006;248:1–41
  6. Shapiro H, Shachar S, Sekler I, Hershfinkel M, Walker MD. Role of GPR40 in fatty acid action on the beta cell line INS-1E. Biochem Biophys Res Commun. 2005;335:97–104
  7. Katsuma S, Hatae N, Yano T, Ruike Y, Kimura M, Hirasawa A, et al. Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J Biol Chem. 2005;280:19507–19515
  8. Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 2005;1:245–258
  9. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes. 2006;2:S16–S23
  10. Lupi R, Del Guerra S, Fierabracci V, Marselli L, Novelli M, Patane G, et al. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes. 2002;51:S134–S137
  11. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. 2002;51:1437–1442
  12. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 2003;442:173–176
  13. Lupi R, Del Guerra S, Mancarella R, Novelli M, Valgimigli L, Pedulli GF, et al. Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. Diabetes Metab. 2007;33:340–345
  14. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155–2163
  15. DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract. 2004;143:9–21
  16. Salehi A, Flodgren E, Nilsson NE, Jimenez-Feltstrom J, Miyazaki J, Owman C, et al. Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res. 2005;322:207–215
  17. Tomita T, Masuzaki H, Iwakura H, Fujikura J, Noguchi M, Tanaka T, et al. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion. Diabetologia. 2006;49:962–968
  18. Schnell S, Schaefer M, Schöfl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol Cell Endocrinol. 2007;263(1–2):173–180
  19. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians. 1999;241:241–248
  20. Zraika S, Dunlop M, Proietto J, Andrikopoulos S. Effects of free fatty acids on insulin secretion in obesity. Obes Rev. 2002;3:103–112
  21. Marchetti P, Del Prato S, Lupi R, Del Guerra S. The pancreatic beta-cell in human type 2 diabetes. Nutr Metab Cardiovasc Dis. 2006;16(Suppl. 1):S3–S6
  22. Winzell MS, Ahrén B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Ther. 2007;116:437–448
  23. Berggren PO, Leibiger IB. Novel aspects on signal-transduction in the pancreatic beta-cell. Nutr Metab Cardiovasc Dis. 2006;16(Suppl. 1):S7–S10
  24. Lan H, Hoos LM, Liu L, Tetzloff G, Hu W, Abbondanzo SJ, et al. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease. Diabetes. 2008 Aug 4;

PII: S0939-4753(09)00039-8

doi: 10.1016/j.numecd.2009.02.008

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 1 , Pages 22-25 , January 2010

Article Tools

* Image Usage & Resolution